Chain Drug Review

DEERFIELD, Ill. — Walgreens and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), today announced a...

By Andrea Leigh
With the rapid advancement of AI, consumers aren’t sure what — or whom — to trust. Trust in institutions, including banks, governments, corporations, news organizations and social media companies, is declining. What’s more, nearly eight in 10 consumers...

Following the British victory over the Axis powers at El Alamein, Prime Minister Winston Churchill said, “Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” The battle, in November 1942, proved...

By David Pinto, founder of Racher Press
Seems like every time chain drug retailing gets involved with the larger outside world, the industry suffers — sometimes unfairly.
The most recent example is the brouhaha surrounding the controversy over PBMs, more commonly known as pharmacy benefit managers. For those who have not yet studied up on the subject, PBMs are the most recent effort to charge (overcharge?) the patient...